MedPath

Moexipril Hydrochloride

Approved
Approval ID

56bf1b0a-463a-4324-957b-585d4cf352ee

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 14, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Moexipril Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5928
Application NumberANDA078454
Product Classification
M
Marketing Category
C73584
G
Generic Name
Moexipril Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateApril 14, 2011
FDA Product Classification

INGREDIENTS (5)

MAGNESIUM CARBONATEInactive
Code: 0E53J927NA
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
MOEXIPRIL HYDROCHLORIDEActive
Quantity: 7.5 mg in 1 1
Code: Q1UMG3UH45
Classification: ACTIB
COPOVIDONEInactive
Code: D9C330MD8B
Classification: IACT
ZINC STEARATEInactive
Code: H92E6QA4FV
Classification: IACT

Moexipril Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-4883
Application NumberANDA078454
Product Classification
M
Marketing Category
C73584
G
Generic Name
Moexipril Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateApril 14, 2011
FDA Product Classification

INGREDIENTS (5)

MOEXIPRIL HYDROCHLORIDEActive
Quantity: 15 mg in 1 1
Code: Q1UMG3UH45
Classification: ACTIB
MAGNESIUM CARBONATEInactive
Code: 0E53J927NA
Classification: IACT
ZINC STEARATEInactive
Code: H92E6QA4FV
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
COPOVIDONEInactive
Code: D9C330MD8B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Moexipril Hydrochloride - FDA Drug Approval Details